Viewing Study NCT02128932


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-02-24 @ 2:06 PM
Study NCT ID: NCT02128932
Status: COMPLETED
Last Update Posted: 2019-06-13
First Post: 2014-04-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
Sponsor:
Organization: